Suwon-si, South Korea

Tae Cheul Roh




Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Tae Cheul Roh: Pioneering Patents in Pharmaceutical Development

Introduction: Tae Cheul Roh, a prominent inventor based in Suwon-si, South Korea, has made significant contributions to the field of pharmaceuticals with three patents to his name. His innovative work focuses on compounds that have the potential to address critical health issues, particularly metabolic syndromes.

Latest Patents: Among his latest inventions, Roh has developed a compound known as a 1,2-naphthoquinone based derivative. This compound and its various forms, including pharmaceutically acceptable salts, hydrates, and diastereomers, are designed for treatment or prevention of metabolic syndromes. The applied methods for preparing these compounds enhance their effectiveness and usability in pharmaceuticals, reflecting Roh's commitment to advancing medical science.

Career Highlights: Tae Cheul Roh has worked with esteemed companies such as Yungjin Pharm Co., Ltd. and Huen Co., Ltd., where he has played a vital role in driving research and development forward. His work at these organizations has been pivotal in bringing innovative pharmaceutical solutions to market.

Collaborations: Throughout his career, Roh has collaborated with talented professionals including Whee Seong Lee and Mi Jung Lee. Their combined expertise has fostered a productive research environment, leading to the successful completion of significant projects and the enhancement of pharmaceutical methodologies.

Conclusion: Tae Cheul Roh stands out as a notable inventor whose work in developing 1,2-naphthoquinone based derivatives showcases his innovative spirit. With a focus on impactful health solutions and a collaborative approach, Roh continues to contribute significantly to the pharmaceutical industry, paving the way for future advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…